Nasal continuous positive airway pressure: Influence on digital volume pulse in obstructive sleep apnoea patients

European Respiratory Journal

Volumn 39, Issue 5, 2012, Pages 1127-1135

  Scholze, Alexandra ^a,b,c   Lamwers, Stephanie ^d   Tepel, Martin ^a,b,c   Sanner, Bernd M ^d  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Institute for Clinical Research   (Denmark)

^d Bethesda Krankenhaus   (Germany)

Author keywords

Digital volume pulse wave; Nasal continuous positive airway pressure; Obstructive sleep apnoea; Vasoconstriction

Indexed keywords

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTOELECTRIC PLETHYSMOGRAPHY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; SLEEP; SLEEP APNEA SYNDROME; VASOCONSTRICTION; WAKEFULNESS;

ALGORITHMS; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOPLETHYSMOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; VASOCONSTRICTION;

EID: 84860487969     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00052611     Document Type: Article

References (43)

1. Pack AI. Advances in sleep-disordered breathing. Am J Respir Crit Care Med 2006; 173: 7-15. (Pubitemid 43069783)
2. Basner RC. Continuous positive airway pressure for obstructive sleep apnea. N Engl J Med 2007; 356: 1751-1758. (Pubitemid 46661544)
3. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053. (Pubitemid 40386782)
4. Buchner NJ, Sanner BM, Borgel J, et al. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 2007; 176: 1274-1280. (Pubitemid 350256482)
5. Fletcher EC. Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 2001; 90: 1600-1605.
6. Fletcher EC, Orolinova N, Bader M. Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 2002; 92: 627-633. (Pubitemid 34671030)
7. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51. (Pubitemid 36188305)
8. Millasseau SC, Kelly RP, Ritter JM, et al. The vascular impact of aging and vasoactive drugs: comparison of two digital volume pulse measurements. Am J Hypertens 2003; 16: 467-472. (Pubitemid 36667801)
9. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107: 2864-2869. (Pubitemid 36705999)
10. Sanner BM, Tepel M, Markmann A, et al. Effect of continuous positive airway pressure therapy on 24-hour blood pressure in patients with obstructive sleep apnea syndrome. Am J Hypertens 2002; 15: 251-257. (Pubitemid 34226191)
11. Barbé F, Duran-Cantolla J, Capote F, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 181: 718-726.
12. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension. Chest 2006; 129: 1459-1467. (Pubitemid 43894973)
13. Imadojemu VA, Mawji Z, Kunselman A, et al. Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest 2007; 131: 1406-1412.
14. Heitmann J, Ehlenz K, Penzel T, et al. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 2004; 23: 255-262.
15. American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated events. Westchester, American Academy of Sleep Medicine, 2007.
16. American Thoracic Society, Medical Section of the American Lung Association. Indications and standards for cardiopulmonary sleep studies. Am Rev Respir Dis 1989; 139: 559-568.
17. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999; 22: 667-689.
18. Scholze A, Burkert A, Mardanzai K, et al. Increased arterial vascular tone during the night in patients with essential hypertension. J Hum Hypertens 2007; 21: 60-67. (Pubitemid 44921820)
19. Wittrock M, Scholze A, Compton F, et al. Noninvasive pulse wave analysis for the determination of central artery stiffness. Microvasc Res 2009; 77: 109-112.
20. Rechtschaffen A, Kales A, eds. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages in Human Subjects. Washington, Public Health Service, US Government Printing Office, 1968.
21. Punjabi NM, Newman AB, Young TB, et al. Sleep-disordered breathing and cardiovascular disease. An outcome-based definition of hypopneas. Am J Respir Crit Care Med 2008; 177: 1150-1155. (Pubitemid 351717575)
22. Gilmartin GS, Tamisier R, Curley M, et al. Ventilatory, hemodynamic, sympathetic nervous system and vascular reactivity changes following recurrent nocturnal sustained hypoxia in humans. Am J Physiol Heart Circ Physiol 2008; 295: H778-H785.
23. Imadojemu VA, Mawji Z, Kunselman A, et al. Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest 2007; 131: 1406-1413. (Pubitemid 46762346)
24. Ip MS, Tse HF, Lam B, et al. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004; 169: 348-353. (Pubitemid 38134813)
25. Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607-2610.
26. Gjørup PH, Sadauskiene L, Wessels J, et al. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 2007; 20: 44-52. (Pubitemid 46014056)
27. Møller DS, Lind P, Strunge B, et al. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003; 16: 274-280. (Pubitemid 36384754)
28. Yamauchi M, Kimura H. Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications. Antioxid Redox Signal 2008; 10: 755-768. (Pubitemid 351225902)
29. Dorkova Z, Petrasova D, Molcanyiova A, et al. Effects of CPAP on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 2008; 134: 686-692.
30. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of Creactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107: 1129-1134. (Pubitemid 36297204)
31. Stein PK, Pu Y. Heart rate variability, sleep and sleep disorders. Sleep Med Rev 2012; 16: 47-66.
32. Otter HP, Baust W. Experiments on cholinergic mechanisms for the control of tonic and phasic components of REM sleep. Electroenceph Clin Neurophysiol 1970; 29: 206-219.
33. Dodt C, Breckling U, Derad I, et al. Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 1997; 30: 71-76. (Pubitemid 27306349)
34. Kushida CA, Littner MR, Hirshkowitz M, et al. Practice parameters for the use of continuous and bilevel positive airway pressuredevices to treat adult patients with sleep-related breathing disorders. Sleep 2006; 29: 375-380. (Pubitemid 44019961)
35. Weaver TE, Maislin G, Dinges DF, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily function. Sleep 2007; 30: 711-719. (Pubitemid 46854758)
36. Barbé F, Duran-Cantolla J, Capote F, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 181: 718-726.
37. Marrone O, Salvaggio A, Bue AL, et al. Blood pressure changes after automatic and fixed CPAP in obstructive sleep apnea: relationship with nocturnal sympathetic activity. Clin Exp Hypertens 2011; 33: 373-380.
38. Narkiewicz K, van de Borne PJ, Pesek CA, et al. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 1999; 99: 1183-1189. (Pubitemid 29120090)
39. Sanner BM, Kollhosser P, Buechner N, et al. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J 2004; 23: 601-604. (Pubitemid 38456004)
40. Correia ML, Morgan DA, Sivitz WI, et al. Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure. Hypertension 2001; 37: 936-942. (Pubitemid 32221617)
41. Fietze I, Quispe-Bravo S, Hänsch T, et al. Arousal and sleep stages in patients with obstructive sleep apnoea syndrome: changes under nCPAP treatment. J Sleep Res 1997; 6: 128-133. (Pubitemid 27300271)
42. Verma A, Radtke RA, VanLandingham KE, et al. Slow wave sleep rebound and REM rebound following the first night of treatment with CPAP for sleep apnea: correlation with subjective improvement in sleep quality. Sleep Med 2001; 2: 215-223. (Pubitemid 34846770)
43. Norman RG, Pal I, Stewart C, et al. Interobserver agreement among sleep scorers from different centers in a large dataset. Sleep 2000; 23: 901-908.